|
LYRA Lyra Therapeutics Inc 1327273 |
| Balance Sheet |
|
Current Assets
|
$16,272,000.00 |
|
Assets
|
$36,108,000.00 |
|
Current Liabilities
|
$9,522,000.00 |
|
Liabilities
|
$46,825,000.00 |
|
Equity
|
$-10,717,000.00 |
|
Shares Out
|
1774882.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-28,859,000.00 |
|
Investing Cash Flow
|
$-98,000.00 |
| Market Analysis |
Market Cap
|
$337,227.58 |
|
Price
|
$0.19 |
|
PB
|
0.38 |
|
EPS
|
-18.62 |
|
PS
|
0.89 |
|
FCF
|
$-28,975,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-10-01 09:32:04 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-10-26 10:00:47 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LYRA documents filed with the SEC.
LYRA Filings
Clear
